VXR 107 (Venlafaxine Hydrochloride Extended-Release 150 mg)
Pill with imprint VXR 107 is Red, Capsule-shape and has been identified as Venlafaxine Hydrochloride Extended-Release 150 mg. It is supplied by Orchid Healthcare.
Venlafaxine is used in the treatment of autism; anxiety; depression; generalized anxiety disorder; major depressive disorder and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for VXR 107
Venlafaxine Hydrochloride Extended-Release
- Imprint
- VXR 107
- Strength
- 150 mg
- Color
- Red
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Serotonin-norepinephrine reuptake inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Orchid Healthcare
- National Drug Code (NDC)
- 68820-0107
- Inactive Ingredients
-
povidone k90,
magnesium silicate,
ethylcellulose (100 mPa.s),
polyethylene glycol 400,
gelatin,
ferric oxide red,
ferric oxide yellow,
titanium dioxide,
sodium lauryl sulfate,
shellac,
potassium hydroxide,
sucrose,
alcohol,
butyl alcohol,
isopropyl alcohol,
propylene glycol,
ammonia,
water
Note: Inactive ingredients may vary.
More about venlafaxine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (2,577)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: serotonin-norepinephrine reuptake inhibitors
Patient resources
- Drug Information
- Venlafaxine (Advanced Reading)
- Venlafaxine Extended-Release Tablets
- Venlafaxine Tablets
- Venlafaxine Extended-Release Capsules
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.